OUR STORY

ALBUPAD is a spin-off from a leading research center in biomedicine renowned for its strong focus on biomaterials, which still provides R&D support to Albupad innovation process.

Our founders are award-winning scientists committed to transforming patient care. They are supported by an experienced and multidisciplinary advisory board, with deep expertise in drug delivery, biomaterials and pharmacology – including clinicians and translational experts.

MEET THE TEAM

Dr Jordan BEURTON

CTO

Dr Eya ALOUI

CEO

dr benoit frisch

Dr BenoƮt FRISCH

Research Director CNRS

Philippe-Lavalle5

Dr Philippe LAVALLE

Research DIr. INSERM

Pierre site_2

Pr Pierre SCHAFF

Lab Director INSERM

OUR SUPPORTS

ALBUPAD also benefit from seasoned partners in biopharmaceutical business development and financial management, and from a large network in the innovation ecosystem.

ACADEMIC PARTNERS

STRATEGIC PARTNERS

AWARDS